Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias
ATAXIC
2 other identifiers
observational
165
1 country
1
Brief Summary
Congenital ataxias (CA) are rare, non progressive diseases, characterized by psychomotor retardation, hypotonia followed by ataxia. The presence of the "molar tooth" on MRI allowed to define Joubert syndrome, a peculiar form of CA. Apart from this group, CA are mostly associated with cerebellar atrophy or hypoplasia without molar tooth on MRI. CA are a clinically as well as genetically heterogeneous group of diseases. Early-onset ataxias are progressive but may be difficult to distinguish from CA in the first years of the disease. To date, few genes responsible for CA have been identified: ABC7 (X-linked CA associated with sideroblastic anemia), SLC9A6 (X-linked CA associated with severe mental retardation, autism and epilepsy), GPR56 (CA associated with polymicrogyria), ATCAY (pure CA in Cayman isolate); the involvement of the ATCAY and ABC7 genes has never been assessed in a large cohort of CA patients. Primary objective: To assess the frequency of mutations of the ATCAY and ABC7 genes in patients affected with non Joubert congenital or early-onset ataxia. Secondary objective: To identify new loci and/or genes responsible for CA To further describe the clinical phenotype of the CA and to assess the frequency of the various clinical types (pure CA/CA associated with spasticity/ syndromic CA, congenital/early-onset CA, sporadic/familial CA). To describe the clinical phenotype of CA related to mutations in one of analysed genes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2011
CompletedFirst Posted
Study publicly available on registry
December 8, 2011
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedJune 15, 2015
June 1, 2015
2.8 years
December 6, 2011
June 12, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of the patients with a mutation in one of the analysed genes.
1 day
Secondary Outcomes (2)
Percentage of patients with severe/moderate/mild/absent intellectual deficiency
1 day
Percentage of patients with/without epilepsy/spasticity/extraneurological features and nature and frequency of MRI anomalies
1 day
Study Arms (1)
patients ataxic
Interventions
Blood sample will be analysed in order to check presence or not of mutation in ABC7, SLC9A6, GPR56, ATCAY.
Eligibility Criteria
All types
You may qualify if:
- Patient, child or adult, affected with a congenital or early-onset ataxia defined by:
- Neurological symptoms observed before age of 2 years.
- Non progressive cerebellar ataxia observed at the time of examination. Karyotype done or in progress
You may not qualify if:
- Metabolic disease
- Specific MRI malformations suggesting a peculiar entity : molar tooth (joubert syndrome), superior vermis dysplasia with cleft (Oligophrenin)
- Muscle weakness and elevated creatine phosphokinase (CPK)
- Clearly progressive ataxia.
- Absence of signature of the informed consent.
- Absence of affiliation to social security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Trousseau, Service de Génétique
Paris, 75012, France
Biospecimen
Blood sample
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lydie Burglen, PhD
Assistance Publique
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2011
First Posted
December 8, 2011
Study Start
January 1, 2012
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
June 15, 2015
Record last verified: 2015-06